Kidney Transplant Matching: ABO, HLA, and Beyond — Compatibility Essentials
Kidney transplant success depends on immunologic compatibility to minimize rejection. Matching is multi-layered.
1. ABO Blood Group Compatibility
- Identical: Best (O→O, A→A, B→B, AB→AB).
- Compatible: O→any (universal donor); A→A/AB; B→B/AB; AB→AB only (universal recipient).
- Incompatible: A→B/O, B→A/O, AB→A/B/O. Requires desensitization (plasmapheresis, IVIG, rituximab) — higher rejection risk.
2. HLA Matching (Human Leukocyte Antigen)
- Class I: HLA-A, -B, -C (all nucleated cells) — CD8+ T-cell recognition.
- Class II: HLA-DR, -DQ, -DP (APCs) — CD4+ T-cell recognition.
- Matching level: 0–6 antigen match (A, B, DR). Zero mismatches (6/6) → best graft survival.
- HLA-DR matching most critical for long-term survival.
- Modern immunosuppression (tacrolimus, MMF, prednisone) reduces but doesn't eliminate HLA impact.
3. Sensitization & Antibody Assessment
- PRA (Panel Reactive Antibody): % of donor population recipient reacts with. High PRA (>80%) = highly sensitized → harder match.
- Donor-Specific Antibodies (DSA): Anti-HLA antibodies against donor. Preformed DSA → hyperacute/accelerated rejection. Virtual crossmatch (single antigen bead assay) predicts physical crossmatch.
- Flow crossmatch / CDC crossmatch: Final compatibility test pre-transplant.
4. Additional Factors
- Kidney size/function: Donor kidney mass ~ recipient metabolic demand (weight-based). Pediatric en bloc vs. adult single.
- Age matching: Younger donors → better long-term function; older donors accepted for older recipients (Eurotransplant Senior Program).
- CMV/EBV status: D+/R− highest risk for CMV disease / PTLD; prophylaxis/preemptive therapy.
- ABO-incompatible (ABOi) protocols: Rituximab + plasmapheresis/IVIG + maintenance IS → outcomes approaching ABOc.
Allocation Systems
- US: KAS (Kidney Allocation Score) — longevity matching, sensitization, geography.
- Eurotransplant: ETKAS — HLA match, waiting time, age.
Matching balances immunologic risk, organ utility, and equity. Living donation allows optimal matching; deceased donor uses allocation algorithms.
Kidney Disease - Related Articles
- Renal Threshold Explained: What Happens When It’s Exceeded?
- Kidney Failure vs. Kidney Insufficiency: Definitions, Stages, and Management
- Kidney-Friendly Fruits: Which Ones Are Best?
- Kidney Transplant Compatibility: Why Relatives Aren't Always Matches
- Kidney Stone Pain: Why It Radiates to the Abdomen and Groin, Plus Relief Options
- Understanding Kidney Failure: Causes, Symptoms & Treatment
- Understanding Flank Pain: Causes & When to See a Doctor
